why choose us

First received: August 22, 2023

Clinical Trial: The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Kidney Transplant; Complications

Study Type: INTERVENTIONAL


Official Title: The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Brief Summary: EFFEKTOR is a vanguard, multicenter, phase 2 randomized, double blinded, placebo controlled clinical trial to determine the feasibility, tolerability, safety, and efficacy of finerenone in kidney transplant recipients (KTRs).One hundred fifty (150) KTRs will be randomized in a 2:1 ratio of finerenone to placebo, with two embedded substudies: (i) a kidney biopsy substudy in 50 participants who undergo a research kidney biopsy prior to randomization and at the end of active treatment; and (ii) a functional MRI…

Read more